Efficacy and safety of polyethylene glycol loxenatide as add-on to metformin in patients with type 2 diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 3b trial.
Congrong WangXiaofeng LvZhaohui MoJianhua MaQiu ZhangGangyi YangWeijuan LiuQuanmin LiJian ZhouYuqian BaoWeiping JiaPublished in: Diabetes, obesity & metabolism (2020)
The subcutaneous injection of PEX168 once a week can effectively, continuously and safely improve HbA1c levels in patients with T2D when combined with metformin.